Labcorp to Buy Opko Assets for 872M
Labcorp has agreed to purchase select assets from Opko Health for 722 million dollars in cash plus potential milestone payments. The transaction includes testing operations and the 4Kscore prostate cancer test.
Xurve View
Insights:
Xurve View
LABCORP HOLDINGS INC will acquire select assets from OPKO HEALTH INC's laboratory subsidiary for $722M in cash, plus up to $150M in potential milestone payments. The transaction expands the buyer's clinical diagnostics footprint across the United States. Opko shares rose 20% in premarket trading following Thursday's announcement.
